Cervical Cancer Risk Factors


Cervical cancer often develops quietly, but it is also one of the most preventable cancers. Understanding cervical cancer risk factors can help you make informed decisions about HPV vaccination, cervical screening and follow-up care.
Having a risk factor does not mean that you will develop cervical cancer. Some women with several risk factors never develop it, while others are diagnosed without realizing they were at increased risk. Risk information should guide healthcare decisions, not create fear or blame.
Nearly all cervical cancers are caused by persistent infection with certain high-risk types of human papillomavirus, commonly called HPV. Cervical Cancer Risk Factors | Cervical Cancer | CDC
HPV is extremely common. Most sexually active people acquire it at some point, often without knowing because it usually causes no symptoms. Most HPV infections are controlled by the immune system within one or two years.
The greater concern is a high-risk HPV infection that remains in the cervical cells for several years. Persistent infection can cause abnormal cell changes. Without detection and treatment, some changes may eventually develop into cervical cancer.
HPV types 16 and 18 cause most cervical cancers worldwide, although several other high-risk HPV types can also cause cancer. Cervical Cancer Causes, Risk Factors, and Prevention - NCI
A risk factor increases the likelihood of developing a disease. It does not confirm that cancer is present.
An HPV-positive result does not mean that a woman has cervical cancer. It means that a high-risk type of HPV has been detected. Depending on the HPV type, age, previous results and current findings, the next step may involve repeat testing, a Pap test, colposcopy or biopsy.
If abnormal cervical tissue needs examination, our guide on what a biopsy is and why it may be recommended explains the process.
Persistent high-risk HPV infection is the most important cervical cancer risk factor.
HPV can pass between people through intimate skin-to-skin sexual contact. Penetrative sex is not required for transmission. Condoms can reduce HPV transmission, but they cannot provide complete protection because HPV may affect skin that a condom does not cover. Comprehensive Cancer Information - NCI
A woman may receive a positive HPV result after several previous negative results. This does not necessarily mean that the infection is new. HPV can sometimes become active again after many years.
Researchers do not know whether a reactivated infection has the same likelihood of causing cervical changes as a newly acquired infection. An HPV test also cannot establish when the infection occurred or who transmitted it. A positive result is therefore not proof of recent sexual contact or infidelity. Comprehensive Cancer Information - NCI
A weakened immune system can make it more difficult for the body to control HPV. The infection may be more likely to persist and progress to cervical cancer.
This can affect women who:
The World Health Organization reports that women living with HIV are approximately six times more likely to develop cervical cancer than women without HIV. They may require earlier or more frequent screening according to their medical history and national guidelines. World Health Organization (WHO)
Smoking and exposure to secondhand smoke are associated with an increased risk of cervical cancer. The risk rises with the amount smoked and the level of exposure.
Evidence also indicates that smoking may increase the chance that high-grade cervical cell changes will progress to cancer.
Professional support can make quitting more manageable. Support may include counseling, nicotine replacement products or prescribed medicines. In the United States, free assistance is available through Smokefree.gov and 1-800-QUIT-NOW. People in other countries can ask their healthcare team about local services.
Missing screening does not cause HPV infection. However, it can allow precancerous cervical changes to remain undetected.
Screening can identify high-risk HPV or abnormal cells before cancer develops. Precancer can usually be treated before it becomes invasive cancer. Screening is most effective when abnormal findings receive appropriate follow-up.
Cost, transportation difficulties, lack of paid leave, fear, embarrassment and limited access to services can prevent patients from receiving care. These are healthcare barriers, not personal failures. Patients can ask about community clinics, patient navigation, financial assistance or flexible appointments.
Women who have previously had precancerous cervical cell changes may require continued surveillance after treatment.
Follow-up recommendations consider current results, previous screening results, previous treatment and personal health factors such as age. A patient may be advised to have repeat HPV testing, repeat HPV and Pap cotesting, colposcopy, biopsy or treatment.
Do not stop follow-up care simply because treatment has been completed or current symptoms are absent.
Research has found an association between using oral contraceptive pills for five years or longer and an increased risk of cervical cancer.
The association may be indirect because hormones may affect how cervical cells respond to persistent HPV infection. The observed risk generally increases with longer use and declines after oral contraceptives are stopped.
This does not mean that birth control pills are unsuitable for every woman. Do not stop prescribed contraception without medical guidance. Discuss your duration of use, individual health history and possible alternatives with a qualified healthcare professional.
Giving birth to several children is associated with a higher risk of cervical cancer. Researchers do not fully understand the reasons for this association.
Pregnancy and family size should never become reasons to blame a patient. This information is considered alongside HPV status, smoking, immune health, screening history and other risk factors.
Obesity is included among cervical cancer risk factors because cervical screening may be more difficult, potentially leading to lower detection of precancerous changes.
Body size should never become a reason to delay or avoid care. Every patient deserves respectful communication, appropriate equipment and a screening examination that protects their dignity.
If a previous examination was uncomfortable or unsuccessful, discuss your concerns with the healthcare team before the next appointment.
Diethylstilbestrol, commonly called DES, is a synthetic estrogen that was prescribed to some pregnant women, particularly between 1940 and 1971.
Women exposed to DES while developing in the womb have an increased risk of a rare cancer called clear cell adenocarcinoma of the cervix or vagina. The absolute risk remains low, but affected women may require individualized screening.
If you believe your mother took DES during pregnancy, inform your healthcare professional.
People who began sexual activity at a younger age, particularly before age 18, or have had multiple sexual partners are more likely to acquire a high-risk HPV infection. A partner’s sexual history can also affect exposure.
These are population-level associations, not judgments about anyone’s behavior. A person can acquire HPV from one partner, and either person may carry it without symptoms.
Stigma can discourage people from attending screening or discussing their results. Cervical cancer education should provide information without shame.
HPV vaccination provides strong protection against the types of HPV that cause most cervical cancers. However, it does not protect against every high-risk type and cannot treat an infection that is already present.
In the United States, the CDC recommends:
Vaccination is not routinely recommended for everyone aged 27 through 45 because many adults have already encountered HPV. Some may still benefit after discussing their individual circumstances with a clinician.
Recommendations vary by country. Vaccinated women should continue cervical screening because the vaccine does not cover every cancer-causing HPV type.
Not every cervical cancer risk factor can be changed, but several actions can reduce risk:
Learn more about cervical cancer symptoms and when to seek medical attention.
Risk factors indicate who may have a greater chance of developing cervical cancer. Symptoms are physical changes that may need investigation.
Cervical precancer and early cervical cancer may cause no symptoms. When symptoms occur, they can include unusual vaginal bleeding, bleeding after sex, watery or blood-stained discharge, pelvic pain or pain during sex.
These symptoms can have many noncancerous causes. However, persistent or unexplained changes should be evaluated. Our guide to the early signs of cancer explains how to respond without assuming that every symptom means cancer.
A family member or caregiver can help by:
HPV is common. Nobody deserves blame or humiliation because of an HPV or cervical screening result.
No. Most HPV infections are controlled by the immune system. Persistent infection with a high-risk HPV type is the main concern.
Yes. HPV can be acquired from one partner, and the infection may exist without symptoms.
No. HPV may become detectable again after many years. A test cannot show when the infection was acquired or who transmitted it.
Yes. Smoking and secondhand smoke exposure are associated with increased risk. Smoking may also increase the chance that high-grade cervical changes progress.
Do not stop prescribed contraception based only on general information. Discuss your duration of use, benefits, risks and alternatives with your healthcare professional.
Yes. HPV vaccination does not protect against every high-risk HPV type.
No. A normal result is reassuring at the time of testing, but it does not provide lifelong protection. Continue screening at the recommended interval.
This source-supported article provides reliable information to strengthen your understanding of cervical cancer risk factors and complement personalized medical guidance from a qualified healthcare professional who understands your individual findings and history.
Centers for Disease Control and Prevention. (n.d.). Cervical cancer risk factors.https://www.cdc.gov/cervical-cancer/risk-factors/index.html
Centers for Disease Control and Prevention. (n.d.). Reducing risk for cervical cancer.https://www.cdc.gov/cervical-cancer/prevention/index.html
National Cancer Institute. (n.d.). Cervical cancer causes, risk factors, and prevention.https://www.cancer.gov/types/cervical/causes-risk-prevention
National Cancer Institute. (n.d.). HPV and cancer.https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer
National Cancer Institute. (n.d.). HPV and Pap test results.https://www.cancer.gov/types/cervical/screening/abnormal-hpv-pap-test-results
National Cancer Institute. (n.d.). Oral contraceptives and cancer risk.https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/oral-contraceptives-fact-sheet
World Health Organization. (n.d.). Cervical cancer.https://www.who.int/news-room/fact-sheets/detail/cervical-cancer